Papa, M.L.; Capasso, F.; Pudore, L.; Torre, S.; Mango, S.; Russo, V.; Delrio, P.; Palaia, R.; Ruffolo, F.; d’Eufemia, M.D.; De Lucia, D.; Napolitano, M.; Di Micco, P.; Parisi, V.
(Experimental Oncology, 2007)
Background: Quantification of the magnitude of thrombotic risk associated with malignancy and with anti-cancer therapy is indispensable to use anticoagulant drugs which selectively interfere with haemostatic mechanisms ...